| datacite.subject.fos | Ciências Médicas::Ciências da Saúde | |
| datacite.subject.sdg | 03:Saúde de Qualidade | |
| dc.contributor.author | Pereira, Cidália | |
| dc.contributor.author | Monteiro, Rosário | |
| dc.contributor.author | Martins, Maria João | |
| dc.date.accessioned | 2025-12-15T16:01:22Z | |
| dc.date.available | 2025-12-15T16:01:22Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | 2.3.1 Introduction For quite some time, it has been identified that high blood pressure, dyslipidemia [increased triglycerides and reduced high-density lipoprotein (HDL) cholesterol levels], impaired glucose homeostasis and abdominal obesity take place concurrently more than by random, supporting the existence of the metabolic syndrome (MetSyn). Additionally, hyperuricemia, a prothrombotic state, oxidative stress, chronic low grade inflammation, increased levels of apolipoprotein-B and small dense low density lipoprotein (LDL) cholesterol (contributing to atherogenic dyslipidemia), non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis, obstructive sleep apnea and/or polycystic ovarian disease (Fulop, 2006; Alberti, 2009; Roberts, 2009; Ma, 2012; Matsuda, 2013; Mule, 2014; Carson, 2015) are quite often present on the MetSyn, although not yet included in its current/actual definition. Taking this into consideration, it is not surprising that the MetSyn associates with an increased risk of type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (Fulop, 2006; Qiao, 2007; Carson, 2015). | eng |
| dc.description.sponsorship | Acknowledgements: This work has been supported by FCT (Fundação para a Ciência e Tecnologia, PEst-OE/SAU/UI0038/2014) and Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal. We thank Unicer Bebidas, S.A. (Leça do Balio, Matosinhos, Portugal) the supply of the Portuguese natural mineral-rich water tested. | |
| dc.identifier.citation | Pereira, C., Monteiro, R. & João Martins, M. (2015). 2.3 Understanding the Metabolic Syndrome Using a Biomedical Chemistry Profile. In Biomedical Chemistry: Current Trends and Developments (pp. 132-147). Warsaw, Poland: De Gruyter Open Poland. https://doi.org/10.1515/9783110468755-005 | |
| dc.identifier.doi | 10.1515/9783110468755-005 | |
| dc.identifier.isbn | 978-311046875-5 | |
| dc.identifier.issn | 978-311046874-8 | |
| dc.identifier.uri | http://hdl.handle.net/10400.8/15057 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | De Gruyter | |
| dc.relation | Strategic Project - UI 38 - 2014 | |
| dc.relation.hasversion | https://www.degruyterbrill.com/document/doi/10.1515/9783110468755-005/html?lang=de&srsltid=AfmBOopjjb-KAvP40YR1APWWe-JULkYtsoHEsRDnutTQzzXvay2FMZRk | |
| dc.relation.ispartof | Biomedical Chemistry | |
| dc.rights.uri | N/A | |
| dc.subject | Metabolic Syndrome | |
| dc.title | Understanding the Metabolic Syndrome Using a Biomedical Chemistry Profile | eng |
| dc.title.alternative | 2.3 Understanding the Metabolic Syndrome Using a Biomedical Chemistry Profile | eng |
| dc.type | book part | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Strategic Project - UI 38 - 2014 | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FSAU%2FUI0038%2F2014/PT | |
| oaire.citation.endPage | 147 | |
| oaire.citation.startPage | 132 | |
| oaire.citation.title | Biomedical Chemistry: Current Trends and Developments | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
| person.familyName | Pereira | |
| person.givenName | Cidália Almeida | |
| person.identifier.ciencia-id | AC15-8934-CC03 | |
| person.identifier.orcid | 0000-0001-9934-9648 | |
| person.identifier.rid | GPP-6411-2022 | |
| person.identifier.scopus-author-id | 56016000600 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| relation.isAuthorOfPublication | a4dd40ab-92e7-42e2-8a47-99f2f3879b89 | |
| relation.isAuthorOfPublication.latestForDiscovery | a4dd40ab-92e7-42e2-8a47-99f2f3879b89 | |
| relation.isProjectOfPublication | c73087cc-b9ec-4b97-8ac3-7f0f6655d2b7 | |
| relation.isProjectOfPublication.latestForDiscovery | c73087cc-b9ec-4b97-8ac3-7f0f6655d2b7 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Understanding the Metabolic Syndrome Using a Biomedical Chemistry Profile.pdf
- Size:
- 110.34 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.32 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
